Patent Assignment
Reel/Frame 052165/0230
Change of Name
Recorded: 2020-03-13
Pages: 6
Assignor
NLS-1 PHARMA AG
Executed: 2019-07-17
Assignee
NLS PHARMACEUTICS AG
ALTER POSTPLATZ 2, STANS, 6370, SWITZERLAND
Covered Property
(1)
Mazindol Treatment for Heroin Dependence and Substance Use Disorder
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.